Tessier PM - Search Results

1

Unlocking the potential of agonist antibodies for treating cancer using antibody engineering.

Jhajj HS, Lwo TS, Yao EL, Tessier PM. Jhajj HS, et al. Among authors: tessier pm. Trends Mol Med. 2023 Jan;29(1):48-60. doi: 10.1016/j.molmed.2022.09.012. Epub 2022 Nov 4. Trends Mol Med. 2023. PMID: 36344331 Free PMC article. Review.

2

Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility.

Rabia LA, Desai AA, Jhajj HS, Tessier PM. Rabia LA, et al. Among authors: tessier pm. Biochem Eng J. 2018 Sep 15;137:365-374. doi: 10.1016/j.bej.2018.06.003. Epub 2018 Jun 5. Biochem Eng J. 2018. PMID: 30666176 Free PMC article.

3

Toward Drug-Like Multispecific Antibodies by Design.

Sawant MS, Streu CN, Wu L, Tessier PM. Sawant MS, et al. Among authors: tessier pm. Int J Mol Sci. 2020 Oct 12;21(20):7496. doi: 10.3390/ijms21207496. Int J Mol Sci. 2020. PMID: 33053650 Free PMC article. Review.

4

Agonist antibody discovery: Experimental, computational, and rational engineering approaches.

Schardt JS, Jhajj HS, O'Meara RL, Lwo TS, Smith MD, Tessier PM. Schardt JS, et al. Among authors: tessier pm. Drug Discov Today. 2022 Jan;27(1):31-48. doi: 10.1016/j.drudis.2021.09.008. Epub 2021 Sep 24. Drug Discov Today. 2022. PMID: 34571277 Free PMC article. Review.

5

Simplifying complex antibody engineering using machine learning.

Makowski EK, Chen HT, Tessier PM. Makowski EK, et al. Among authors: tessier pm. Cell Syst. 2023 Aug 16;14(8):667-675. doi: 10.1016/j.cels.2023.04.009. Cell Syst. 2023. PMID: 37591204 Review.

6

Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily.

Jhajj HS, Schardt JS, Khalasawi N, Yao EL, Lwo TS, Kwon NY, O'Meara RL, Desai AA, Tessier PM. Jhajj HS, et al. Among authors: tessier pm. bioRxiv [Preprint]. 2023 Dec 12:2023.12.11.571146. doi: 10.1101/2023.12.11.571146. bioRxiv. 2023. PMID: 38168220 Free PMC article. Updated. Preprint.

7

Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.

Jhajj HS, Schardt JS, Khalasawi N, Yao EL, Lwo TS, Kwon NY, O'Meara RL, Desai AA, Tessier PM. Jhajj HS, et al. Among authors: tessier pm. Cell Chem Biol. 2024 May 16;31(5):944-954.e5. doi: 10.1016/j.chembiol.2024.03.010. Epub 2024 Apr 22. Cell Chem Biol. 2024. PMID: 38653243

8

Toward aggregation-resistant antibodies by design.

Lee CC, Perchiacca JM, Tessier PM. Lee CC, et al. Among authors: tessier pm. Trends Biotechnol. 2013 Nov;31(11):612-20. doi: 10.1016/j.tibtech.2013.07.002. Epub 2013 Aug 7. Trends Biotechnol. 2013. PMID: 23932102 Review.

9

Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.

Alam ME, Geng SB, Bender C, Ludwig SD, Linden L, Hoet R, Tessier PM. Alam ME, et al. Among authors: tessier pm. Mol Pharm. 2018 Jan 2;15(1):150-163. doi: 10.1021/acs.molpharmaceut.7b00779. Epub 2017 Dec 6. Mol Pharm. 2018. PMID: 29154550

10

Selecting and engineering monoclonal antibodies with drug-like specificity.

Starr CG, Tessier PM. Starr CG, et al. Among authors: tessier pm. Curr Opin Biotechnol. 2019 Dec;60:119-127. doi: 10.1016/j.copbio.2019.01.008. Epub 2019 Feb 26. Curr Opin Biotechnol. 2019. PMID: 30822699 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page